Her primary areas of investigation include Pathology, Transplantation, Kidney transplantation, Internal medicine and Immunology. Her Pathology research includes elements of Kidney pathology, Transplant glomerulopathy and Acute tubular necrosis. Her studies in Transplant glomerulopathy integrate themes in fields like Antibody, Immunopathology and Chronic allograft nephropathy.
Her work deals with themes such as Grading, Clinical trial, MEDLINE and Intensive care medicine, which intersect with Transplantation. Her Kidney transplantation research incorporates elements of Apoptosis, Allograft rejection, Biopsy and Urology. Many of her research projects under Internal medicine are closely connected to HIV-associated nephropathy with HIV-associated nephropathy, tying the diverse disciplines of science together.
Lorraine C. Racusen spends much of her time researching Internal medicine, Pathology, Kidney, Transplantation and Immunology. Her research integrates issues of Gastroenterology and Endocrinology in her study of Internal medicine. Her research in Pathology intersects with topics in Transplant glomerulopathy, Renal allograft and Kidney transplantation.
Her Kidney study which covers Reperfusion injury that intersects with Acute kidney injury. Her study in Transplantation is interdisciplinary in nature, drawing from both Grading, Clinical trial, MEDLINE and Intensive care medicine. Her work on Human leukocyte antigen, Inflammation and Plasmapheresis as part of general Immunology research is often related to HIV-associated nephropathy, thus linking different fields of science.
Her main research concerns Internal medicine, Pathology, Kidney transplantation, Transplantation and Biopsy. Her work in Internal medicine tackles topics such as Gastroenterology which are related to areas like Congenital cytomegalovirus infection, Ulcerative colitis and Pediatric surgery. Lorraine C. Racusen has included themes like MEDLINE, Nephropathy, Intensive care medicine, Banff Classification and Antibody in her Pathology study.
Her work on Transplant glomerulopathy as part of general Kidney transplantation study is frequently connected to Human plasma and C1 esterase, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. Her work is dedicated to discovering how Transplantation, Clinical trial are connected with Sequela and other disciplines. The Biopsy study which covers Immunology that intersects with Oxidative stress and Pharmacology.
The scientist’s investigation covers issues in Pathology, Transplantation, Kidney transplantation, Clinical trial and Biopsy. The concepts of her Pathology study are interwoven with issues in Native kidney and Nephropathy. She interconnects Oncology and MEDLINE in the investigation of issues within Transplantation.
Her work in the fields of Transplant glomerulopathy overlaps with other areas such as Reporting system. Her Transplant glomerulopathy research is multidisciplinary, relying on both Serology and Arteritis. Her Clinical trial study is concerned with the field of Internal medicine as a whole.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Banff 97 working classification of renal allograft pathology
Lorraine C. Racusen;Kim Solez;Robert B. Colvin;Stephen M. Bonsib.
Kidney International (1999)
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
K. Solez;R. B. Colvin;L. C. Racusen;M. Haas.
American Journal of Transplantation (2008)
International standardization of criteria for the histologic diagnosis of renal allograft rejection : the Banff working classification of kidney transplant pathology
K.i.m. Solez;Roy A. Axelsen;Hallgrimur Benediktsson;James F. Burdick.
Kidney International (1993)
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN').
K. Solez;R. B. Colvin;L. C. Racusen;B. Sis.
American Journal of Transplantation (2007)
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.
Lorraine C. Racusen;Robert B. Colvin;Kim Solez;Michael J. Mihatsch.
American Journal of Transplantation (2003)
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions
M. Haas;B. Sis;L. C. Racusen;K. Solez.
American Journal of Transplantation (2014)
Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups
B. Sis;M. Mengel;M. Haas;R. B. Colvin.
American Journal of Transplantation (2010)
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
M. Haas;A. Loupy;C. Lefaucheur;C. Roufosse.
American Journal of Transplantation (2018)
PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS
Robert A. Montgomery;Andrea A. Zachary;Lorraine C. Racusen;Mary S. Leffell.
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Francesco P. Schena;Michael D. Pascoe;Josefina Alberu;Maria del Carmen Rial.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: